Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Research reveals immune suppressive role of soluble antibodies in tumor progression

Research reveals immune suppressive role of soluble antibodies in tumor progression

Experimental peptide drug shows promise against acute myeloid leukemia

Experimental peptide drug shows promise against acute myeloid leukemia

Research identifies link between rare gene variants and survival after blood and marrow transplant

Research identifies link between rare gene variants and survival after blood and marrow transplant

Scripps Florida researchers awarded $2.875 million to destroy common form of leukemia

Scripps Florida researchers awarded $2.875 million to destroy common form of leukemia

Study finds link between industry payments and prescription practices for two cancer types

Study finds link between industry payments and prescription practices for two cancer types

People living near oil and gas facilities may have greater health risks

People living near oil and gas facilities may have greater health risks

Scientists identify key genetic events responsible for initiating childhood leukemia

Scientists identify key genetic events responsible for initiating childhood leukemia

Study uncovers mechanism causing chronic GVHD after bone marrow transplant

Study uncovers mechanism causing chronic GVHD after bone marrow transplant

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

Leukemia itself may increase risk for long-term neurocognitive problems in survivors

Leukemia itself may increase risk for long-term neurocognitive problems in survivors

Salk scientists discover protein that 'turns off' uncontrolled liver cancer growth

Salk scientists discover protein that 'turns off' uncontrolled liver cancer growth

FDA-approved inhibitors could be repurposed to target ARID1A-mutant ovarian cancers

FDA-approved inhibitors could be repurposed to target ARID1A-mutant ovarian cancers

MSU scientists test promising drug to prevent cancer in high-risk patients

MSU scientists test promising drug to prevent cancer in high-risk patients

Researchers probe RNA epigenetics and chromatin structures to predict drug resistance in leukemia

Researchers probe RNA epigenetics and chromatin structures to predict drug resistance in leukemia

Researchers find investigational compound to treat triple negative breast cancer after brain metastasis

Researchers find investigational compound to treat triple negative breast cancer after brain metastasis

Researchers show how two cancer genes work together to trigger leukemia

Researchers show how two cancer genes work together to trigger leukemia

IBN’s green tea-based drug nanocarriers show superior tumor-killing performance

IBN’s green tea-based drug nanocarriers show superior tumor-killing performance

NIH-funded researchers use CRISPR to rapidly find new genetic suspects behind ALS, FTD

NIH-funded researchers use CRISPR to rapidly find new genetic suspects behind ALS, FTD

Adolescent, young adult cancer survivors have stronger social networks than non-cancer peers

Adolescent, young adult cancer survivors have stronger social networks than non-cancer peers

Study finds prevalence of cognitive decline among elderly patients with blood-related cancers

Study finds prevalence of cognitive decline among elderly patients with blood-related cancers